When NB is not diagnosed by BMA examination but is investigated in patients with an NB diagnosis that is both suspected regarding hemato-oncology and histopathologically confirmed by biopsy, confidence in these MFC findings of CD45−/CD56+ cells is increased. This evidence concerns the gene NCAM1 and neuroblastoma.